How do protein aggregates contribute to neurodegenerative disorders, and can they be therapeutically targeted? In this issue of Neuron, Stojkovska et al. (2022) show that aggregated α-synuclein disrupts ER and lysosomal function in Parkinson's disease patient-derived neurons and that combined enhancement of multiple arms of the proteostasis network improves these defects.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neuron.2022.01.016 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!